Way back in the days of wiping down your groceries, I thought new COVID+ was a contraindication to surgery. Happy to discover that was wrong. Zach Weitzner Max Schumm UCLA General Surgery Residency Program

Max Schumm starting off #ASC2022 strong with his research on thyroid cancer management and more patient involvement in the decision making process. James Wu. UCLA General Surgery Residency Program David Geffen School of Medicine at UCLA UCLA Surgery UCLA Health

In this pod: •4 gland vs MIP •Nerve monitoring yes vs no •Age cut-off for parathyroid surgery Young, hip endocrine surgeons (Masha Livhits Vivek Sant, MD James Wu) vs near-boomer Michael Yeh Rivfka Shenoy, MD, MS Max Schumm UCLA General Surgery Residency Program

Grateful for the opportunity to present our work and to listen and learn from experts in this amazing field American Association of Endocrine Surgeons UCLA General Surgery Residency Program

Our newest pod, challenging thyroid cancer cases with special guest Dr. Kepal Patel from NYU! Spoiler alert he uses nerve monitoring UCLA General Surgery Residency Program American Association of Endocrine Surgeons Michael Yeh Masha Livhits Vivek Sant, MD Rivfka Shenoy, MD, MS Max Schumm

This study has laid the groundwork for prospective automated surveillance of incidental adrenal nodules to initiate guideline recommended management at our institution Masha Livhits James Wu Michael Yeh Vivek Sant, MD UCLA Health UCLA General Surgery Residency Program

Our summary by David Toro Tobon Juan P Brito on this study by Max Schumm Masha Livhits @AngelaLeung9 Michael Yeh James Wu examining how clinicians assess and treat #thyroid cancer risk. American Thyroid Association American Association of Endocrine Surgeons AmAcadOtolaryngology AHNS-Endocrine Section Journal of Surgical Oncology ow.ly/3Ehi50LlMWP

Oh my, feeling a little anxious about this one… in which we discuss how to grow a clinical program, “soft skills,” and navigating the job market after surgical training. Special thanks James Wu Rivfka Shenoy, MD, MS Masha Livhits Max Schumm UCLA General Surgery Residency Program

Masha Livhits James Wu Rivfka Shenoy, MD, MS Max Schumm I had so much fun making this with you!

In this decision-making study, >90% of thyroid specialists would comply with pt preference to deviate from their recommended treatment for low- to intermediate-risk DTC! James Wu Michael Yeh Masha Livhits @AngelaLeung9 UCLA General Surgery Residency Program Greg Sacks American Association of Endocrine Surgeons American Thyroid Association

Moving more toward molecular panels like ThyroSeq to determine prognosis, the latest study by Max Schumm Melissa G. Lechner, MD, PhD Michael Yeh Masha Livhits at UCLA Health in JAMA Otolaryngology – Head & Neck Surgery ow.ly/7SEf50PNixz #endotwitter #onctwitter American Association of Endocrine Surgeons AHNS-Endocrine Section

We’re looking forward to this session on the prognostic value of ThyroSeq and sharing some of our work from David Geffen School of Medicine at UCLA UCLA General Surgery Residency Program Michael Yeh Masha Livhits

🌟 This week's TIRO x MDs session is a must-attend! We're honored to have Dr. David Toro-Tobon (David Toro Tobon) present on "Treatment Aggressiveness for Differentiated Thyroid Cancers Varies Widely and is Influenced by Physician's Attitude and Local Practice Environment." 🦋🔬

Beginning of the end…. Thanks for an amazing party paul schmit UCLA General Surgery Residency Program

We FELL off our seats 🪑with the #ChiefResident #GroundRounds lectures! So much accomplished already - watch out world 🌎for these future surgeons !!

#ChiefResident photo tradition - jump shot on the helipad!!

It was so great seeing everyone at #ACSCC2024!! Once a bruin, always a bruin 🧸

On this last day of July, I congratulate all of the endocrine surgery fellows, including our very own Joshua C. Chao, MD, JD and Max Schumm. They are heading to @albanymed and UTSW Surgery, respectively. Best wishes on the next stage of your journey! UCLA General Surgery Residency Program NYU Langone General Surgery Residency